Coagulation, genotypes and recurrent cardiovascular events
Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction
Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells
Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population
Myocardial infarction and cerebrovascular accident following non-cardiac surgery
Predicting the future
Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis
Health-related quality of life in a cohort of adult patients with mild hemophilia A
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)
Prospective multicenter evaluation of the pulmonary embolism rule-out criteria
Venous thromboembolic events and organ-specific occult cancers
A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor
Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency
Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats
Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function
Apixaban, an oral, direct and highly selective factor Xa inhibitor
Developing a new generation of tests for genotyping hemophilia-causative rearrangements involving int22h and int1h hotspots in the factor VIII gene
Thrombostatin FM compounds
Which carboxypeptidase determines the antifibrinolytic potential?
Proteolytic cleavage of carboxypeptidase N markedly increases its antifibrinolytic activity
Insulin inhibition of platelet-endothelial interaction is mediated by insulin effects on endothelial cells without direct effects on platelets
Circulating endothelial cells
CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry
SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human monocytic cells
A case of non-resolving hemophilia B Leyden in a 42-year-old male (F9 promoter + 13 A>G)
Prevalence of type 2b ‘Malmö/New York’ von Willebrand disease in Italy
Long elimination half-life of idraparinux may explain major bleeding and recurrent events of patients from the van Gogh trials
Circulating anticoagulant glycosaminoglycans in mucopolysaccharidosis type I